Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
Omega Diagnostics (CNSL) Share Price & Analysis
2 Followers
CNSL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1.66p - 4.48p
Previous Close3.75p
Volume1.64M
Average Volume (3M)545.91K
Market Cap
£8.92M
Enterprise Value3.88M
Total Cash (Recent Filing)£5.12M
Total Debt (Recent Filing)£74.00K
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Nov 21, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding237,685,200
10 Day Avg. Volume5,746,398
30 Day Avg. Volume545,913
Standard Deviation0.84
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4845.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Omega Diagnostics News
PremiumCompany Announcements
Omega Diagnostics Achieves Strong Financial Turnaround
PremiumCompany Announcements
Omega Diagnostics Announces Upcoming Financial Results
PremiumCompany Announcements
Cambridge Nutritional Sciences Incentivizes Directors
PremiumCompany Announcements
Omega Diagnostics Welcomes New COOOptions Prices
Currently, No data available
---
Ownership Overview
6.56% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
93.44% Public Companies and
Individual Investors
CNSL FAQ
What was Omega Diagnostics Group PLC’s price range in the past 12 months?
Omega Diagnostics Group PLC lowest share price was 1.66p and its highest was 4.48p in the past 12 months.
What is Omega Diagnostics Group PLC’s market cap?
Currently, no data Available
When is Omega Diagnostics Group PLC’s upcoming earnings report date?
Omega Diagnostics Group PLC’s upcoming earnings report date is Nov 21, 2024 which is in 118 days.
How were Omega Diagnostics Group PLC’s earnings last quarter?
Omega Diagnostics Group PLC released its earnings results on Jul 25, 2024. The company reported 0.002p earnings per share for the quarter, beating the consensus estimate of 0.001p by 0.001p.
Is Omega Diagnostics Group PLC overvalued?
According to Wall Street analysts Omega Diagnostics Group PLC’s price is currently Overvalued.
Does Omega Diagnostics Group PLC pay dividends?
Omega Diagnostics Group PLC does not currently pay dividends.
What is Omega Diagnostics Group PLC’s EPS estimate?
Omega Diagnostics Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Omega Diagnostics Group PLC have?
Omega Diagnostics Group PLC has 237,950,650 shares outstanding.
What happened to Omega Diagnostics Group PLC’s price movement after its last earnings report?
Omega Diagnostics Group PLC reported an EPS of 0.002p in its last earnings report, beating expectations of 0.001p. Following the earnings report the stock price went down -12.791%.
Which hedge fund is a major shareholder of Omega Diagnostics Group PLC?
Currently, no hedge funds are holding shares in GB:CNSL
---
Omega Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Omega Diagnostics Group PLC
Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. It has three segments: The Allergy and autoimmune division specialise in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases; The Food intolerance division specialises in the research, development, and production of kits to aid the detection of immune reactions to food; and The Infectious disease division specialises in the research, development, production, and marketing of kits to aid the diagnosis of infectious diseases.
---
Technical Analysis
---